BS EN ISO 21549-7:2007
健康信息学.病患者健康卡数据.药物治疗数据

Health informatics - Patient healthcard data - Medication data

2016-12

 

 

非常抱歉,我们暂时无法提供预览,您可以试试: 免费下载 BS EN ISO 21549-7:2007 前三页,或者稍后再访问。

您也可以尝试购买此标准,
点击右侧 “购买” 按钮开始采购(由第三方提供)。

点击下载后,生成下载文件时间比较长,请耐心等待......

 

标准号
BS EN ISO 21549-7:2007
发布
2007年
发布单位
英国标准学会
替代标准
BS EN ISO 21549-7:2016
当前最新
BS EN ISO 21549-7:2016
 
 
被代替标准
04/30124095 DC:2004
适用范围
This part of ISO 21549 is applicable to situations in which such data are recorded on or transported by patient healthcards compliant with the physical dimensions of ID-1 cards defined by ISO 7810. This part of ISO 21549 specifies the basic structure of the data contained within the medication data object, but does not specify or mandate particular data-sets for storage on devices. The purpose of this part of ISO 21549 is for cards to provide information to other health professionals and to the patient or to their non-professional care giver. It may also be used to carry a new prescription from the prescriber to the dispenser/pharmacy in the design of its sets. Medication data includes the following four components: - medication notes: the list of all medication for a patient; - medication prescriptions: to carry a new prescription from the prescriber to the dispenser/pharmacy; - medication dispensed: the records of medications bought by the patient; - medication references: pointers to other systems that contain information that makes up a medication prescription and the authority to dispense. In order to facilitate interoperability, whenever an application is built for use in the healthcare domain in compliance with this part of ISO 21549, data items required for that application shall be drawn from the list of objects (some of which are extensible) as provided in Clauses 6 to 8. These shall then be used in conjunction with other data defined in other parts of this part of ISO 21549. The detailed functions and mechanisms of the following services are not within the scope of this part of ISO 21549 (although its structures can accommodate suitable data objects elsewhere specified): - the encoding of free text data; - security functions and related services that are likely to be specified by users for data cards depending on their specific application, e.g.: confidentiality protection, data integrity protection and authentication of persons and devices related to these functions; - access control services that may depend on active use of some data card classes such as microprocessor cards; - the initialization and issuing process (which begins the operating lifetime of an individual data card, and by which the data card is prepared for the data to be subsequently communicated to it according to this part of ISO 21549). The following topics are therefore beyond the scope of this part of ISO 21549: - physical or logical solutions for the practical functioning of particular types of data card; - how the message is processed further “downstream” of the interface between two systems; - the form which data take for use outside the data card, or the way in which such data are visibly represented on the data card or elsewhere. It should be noted that not only the definition of “medicinal products” differs from country to country, but also the same name may relate to entirely different products in some countries. Therefore, special attention should be made for the safety of patient, when the card is used across borders. As a matter of course, exchange of prescription across borders must follow all laws, instructions, rules, terms and treaties between the said two countries.

BS EN ISO 21549-7:2007相似标准


推荐

全国首家合理用药重点实验室在穗成立

该实验室主任广州总医院药剂科主任李健介绍,据世界卫生组织的统计数据,全球住院病人三分之一死于不合理用药,而不是疾病本身。老年慢病患者的不合理用药不仅是医疗卫生资源的巨大浪费,更有可能对广大老年慢病患者的生命安全和身体健康构成严重威胁。  ...

新型抗糖尿病药物 可以有效降低肾衰竭的风险

本研究作者汇集了SGLT2抑制剂主要随机对照试验的数据进行了荟萃分析,试验数据报告了对2型糖尿病患者肾脏的影响。总共包括了四项涉及近40000名参与者的研究,评估了三种SGLT2抑制剂格列净、恩格列净(empagliflozin)、达格列净(dapagliflozin)的效果。数据主要来自于CREDENCE研究。...

GSK单吸入器三联疗法“全再乐”于阿里健康平台首发上线!

我们将依托自身优势,借助阿里生态的力量,积极探索‘互联网+医疗健康 ’的创新医疗服务模式,以助力解决中国慢病患者的疾病管理及医疗难题。全再乐是GSK在中国获批的首个一天一次给药的三联慢阻肺治疗药物,凝聚了公司多年投身慢阻肺疾病治疗领域的创新成果。此次全再乐在阿里健康平台实现供应,将为慢阻肺患者提供更广泛及便利的用药资源。...

世卫组织称药物滥用治疗存在巨大空白

  世界卫生组织在6月26日“国际禁毒日”发布新的全球信息系统,记录147个国家预防和治疗酒精及毒品相关问题的资源配置情况。该数据库显示,目前大多数药物滥用疾病患者未得到有效的治疗和护理。  根据该系统,到目前为止,药物依赖在很多国家未被确认为健康问题,与之相关的歧视也成为采取适当治疗的主要障碍,只有82个国家向药物滥用疾病患者提供特别的卫生服务。  ...





Copyright ©2007-2022 ANTPEDIA, All Rights Reserved
京ICP备07018254号 京公网安备1101085018 电信与信息服务业务经营许可证:京ICP证110310号